The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study
Open Access
- 18 October 2017
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 17 (1) , 108
Abstract
Prophylactic pancreatic stents after endoscopic retrograde cholangiopancreatography (ERCP) can help prevent post-ERCP pancreatitis. However most of the pancreatic stents need to be removed by another ERCP. The aim of this observational study was to investigate the feasibility and effectiveness of the modified pancreatic stent system for prevention of post-ERCP pancreatitis. From November 2013 to November 2015, a total of 230 patients who had prophylactic pancreatic stent placed for prevention of post-ERCP pancreatitis at a single institution were identified and stratified. In this case-control design, 150 patients received an ordinary pancreatic stent, and 80 patients received the modified pancreatic stent. The main outcome measures were the difficulty level and complications of pancreatic stent placement and extraction between the two groups. In ordinary group, the average time of pancreatic stent and nasal biliary drainage placement was 3.5 ± 0.6 min. There were 13 cases of stent proximal migration (8.7%), 20 cases of stent spontaneous abscission (13.3%), 5 cases of acute pancreatitis (3.3%) (2 cases for stent abscission) and 7 cases of hyperamylasemia (4.7%) after ERCP. One hundred thirty patients received extra duodenoscope (86.7%) to remove the stent, and 4 cases had acute pancreatitis and 5 patients had hyperamylasemia after removing the proximal migratory stents. In modified group, the average time of pancreatic stent system placement was 4.9 ± 0.7 min, but there was only one case of stent abscission (1.3%), 2 cases of acute pancreatitis (2.5%) and 3 cases of hyperamylasemia (3.8%). The new pancreatic stents were removed directly under x-ray without complication. The modified pancreatic stent system has the same effect of preventing post-ERCP pancreatitis, lower rate of stents proximal migration and spontaneous abscission, and the advantage of easier removed compared with ordinary pancreatic stent.Keywords
This publication has 34 references indexed in Scilit:
- Prevention of Post-Endoscopic Retrograde Cholangiopancreatography PancreatitisPancreas, 2015
- Diclofenac Is Associated With a Reduced Incidence of Post–Endoscopic Retrograde Cholangiopancreatography PancreatitisPancreas, 2014
- Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trialEndoscopy, 2014
- UK wide survey on the prevention of post-ERCP pancreatitisFrontline Gastroenterology, 2013
- Post-ERCP pancreatitis in 2364 ERCP procedures: is intraductal ultrasonography another risk factor?Endoscopy, 2011
- Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysisEndoscopy, 2010
- Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective StudiesAmerican Journal of Gastroenterology, 2007
- Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trialsGastrointestinal Endoscopy, 2004
- Risk Factors for Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography: A Meta-AnalysisEndoscopy, 2003
- Complications of Endoscopic Sphincterotomy: Results From a Single Tertiary Referral CenterEndoscopy, 2002